Alpha DNA Investment Management’s Dynatrace DT Stock Holding History

Alpha DNA Investment Management’s Portfolio DT Stock Details DT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,282	Closed	-$776K	–	62
2024 Q4	$776K	Buy	+14,282	New	+$779K	0.3%	75
2023 Q2	–	Sell	-27,126	Closed	-$1.15M	–	174
2023 Q1	$1.15M	Buy	+27,126	New	+$1.1M	0.34%	71
2021 Q2	–	Sell	-13,123	Closed	-$632K	–	250
2021 Q1	$632K	Buy	+13,123	New	+$637K	0.73%	62

Other funds holding DT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Alpha DNA Investment Management's DT Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Dynatrace (DT) in Q1 2025, closing a stake of 14,282 shares — an estimated $776K sold.

Alpha DNA Investment Management first reported a position in DT in Q1 2021 and held it in 3 quarters. The position peaked at $1.15M in Q1 2023. 601 funds tracked by Wall St. Rank hold DT as of Q1 2025.

Alpha DNA Investment Management reported no remaining Dynatrace position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 14,282 Dynatrace shares in Q1 2025, an estimated $776K.
Alpha DNA Investment Management first reported a position in Dynatrace in Q1 2021 and held it in 3 quarters.
Alpha DNA Investment Management's Dynatrace position peaked at $1.15M in Q1 2023.
601 funds tracked by Wall St. Rank held Dynatrace as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.